{"disease":{"id":"primary-open-angle-glaucoma-or-ocular-hypertension","name":"primary open angle glaucoma or ocular hypertension"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06865144","title":"Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"East Coast Institute for Research","has_results":false},{"nct_id":"NCT07076303","title":"A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Brian Shafer","has_results":false},{"nct_id":"NCT03310580","title":"Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true},{"nct_id":"NCT05075226","title":"Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Maisonneuve-Rosemont Hospital","has_results":false},{"nct_id":"NCT02822742","title":"A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Santen Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03233308","title":"Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Aerie Pharmaceuticals","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}